{"nct_id":"NCT00315731","title":"A Study Of Pharmacokinetics, Whole Body And Organ Dosimetry, And Biodistribution Of Fission-Derived Iodine I 131 Tositumomab (BEXXAR®) For Patients With Previously Untreated Or Relapsed Follicular Or Transformed Non-Hodgkin's Lymphoma","status":"COMPLETED","status_verified_date":"2017-06","start_date":"2003-03-31","start_date_type":"ACTUAL","primary_completion_date":"2006-12-04","primary_completion_date_type":"ACTUAL","completion_date":"2013-06-30","completion_date_type":"ACTUAL","phases":["PHASE1"],"tickers":["GSK"]}